The Efficacy and Safety of Repeat-dose Potenfill for Temporary Penile Enhancement
NCT ID: NCT03840070
Last Updated: 2020-07-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-12-17
2019-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will determine the long-term efficacy and safety of Potenfill.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observational Study to Determine the Efficacy and Safety of Potenfill for Temporary Penile Enhancement
NCT04496427
Efficacy and Safety of Potenfill for Temporary Penile Enhancement
NCT03512717
Clinical Study to CMDHA0101 as Compared to PowerFill® for Temporary Penile Enhancement
NCT03153735
Shafer Width and Girth: The Use of Injectable Fillers for Penile Enhancement
NCT04755634
External Device for Erectile Dysfunction (3D-Erect)
NCT04624126
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Potenfill
Potenfill
Maximum: 22ml
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Potenfill
Maximum: 22ml
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects will sign an informed consent form
Exclusion Criteria
* Allergic to hyalluronic acid.
19 Years
65 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medy-Tox
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Korea university guro hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MT05-KR18PGE1005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.